By Eric Sagonowsky
While much of the world focused on Pfizer and BioNTech’s positive COVID-19 vaccine news on Monday, analysts started gaming out potential ripple effects, namely for companies making coronavirus therapeutics.
read more
By Tina Reed
Former U.S. Surgeon General Vivek Murthy and former Food and Drug Administration Commissioner David Kessler will be among public health leaders guiding the transition team for President-elect Joe Biden regarding COVID-19. Here's who else is in the lineup.
read more
By Conor Hale
The diagnostic developed by GenScript is designed to provide a test result within one hour.
read more
By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner
After Pfizer reported promising efficacy data for its coronavirus vaccine, experts and analysts started speculating about how other vaccine and therapeutics players might fare with their own programs. Moderna is in a strong position, they figured, while therapeutics makers face questions.
read more
By Conor Hale
A low-cost, rapid coronavirus diagnostic developed by researchers at the University of Oxford is now in place to screen passengers at major international airports in London and Hong Kong.
read more
By Paige Minemyer
CVS Health's programs to address COVID-19 have "expanded the universe of people" using its services, CEO Larry Merlo said on a call with investors on Friday.
read more
By Angus Liu
Elderly survivors of COVID-19 and influenza are prone to long-term lung problems. A new study from the Mayo Clinic offers one possible explanation for why older people are more susceptible to lung inflammation and fibrosis following viral infection—and tissue-resident memory CD8+ T cells might be to blame.
read more
By Eric Sagonowsky
President-elect Joe Biden unveiled his COVID-19 transition task force Monday, with Vivek Murthy, David Kessler and Marcella Nunez-Smith co-chairing—and some other bold-faced names in the infectious disease world serving on the panel. First order of business: Working with state and local officials to determine conditions around the country as case counts surge.
read more
By Heather Landi
As employers, universities, and public venues look to safely bring people back into buildings, it has opened up a massive market opportunity for healthcare and tech players. Here is what employers are looking for and the long-term business impact for digital health companies.
read more
By Conor Hale
Researchers at Stanford University have developed a CRISPR-based “lab on a chip” to detect COVID-19, and are working with automakers at Ford to develop their prototype into a market-ready product.
read more
